Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...

The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...

A myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...

Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...

Recent studies have highlighted a link between amyotrophic lateral sclerosis (ALS) and gut microbiota. This prospective study aimed to evaluate the effects of electroacupuncture combined with Chinese ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...

Massachusetts, Cambridge Saturday, March 1, 2025, 18:00 Hrs [IST] ...

WE’RE HEARING FROM A WOMAN LIVING WITH ALS OR LOU GEHRIG’S DISEASE ... SHE HAS FOUND A TRUE LIFELINE IN A CLINICAL TRIAL, AS ONE OF 200 PATIENTS RECEIVING TREATMENT. THAT’S GIVEN HER ...

we are revolutionizing MRI efficiency while reducing environmental impact. These innovations ensure that more patients worldwide can access high-quality imaging, while healthcare providers benefit ...

Attendees can visit AI Exhibition Hall AI-39 to explore how SwiftMR® improves MRI efficiency ... helping providers treat patients more efficiently while maintaining high diagnostic standards.